President Trump's 2025 financial disclosures reveal over 21,000 trades across 1,600 companies, generating more than $2 billion in income, heavily from crypto ventures. His trading strategies include buying the dip, focusing on AI leaders, following government contracts, and portfolio rotation. Notable investments include major SaaS companies and small caps like CoreCivic and Lunar. Additionally, a sponsored segment highlights ConnectU Sciences, a regenerative tissue company addressing GLP-1 drug
President Trump recently released his 2025 trading disclosures, revealing an unprecedented scale of trading activity and significant income generation. This article breaks down the key trades, timing, strategies, and new positions, including a stock with potential for a 10x return. Additionally, we explore a sponsored segment on ConnectU Sciences, a regenerative tissue company addressing emerging market needs.
The Office of Government Ethics released a massive 927-page disclosure, a fourfold increase from the previous year's 234 pages. It documents over 21,000 securities trades across eight investment accounts involving approximately 1,600 companies. On average, Trump's accounts executed about 85 trades every market day, an unprecedented level for a sitting president.
Trump's reported income for 2025 exceeds $2 billion, with approximately $1.2 billion tied directly to crypto ventures and investments. Notably, about $580 million came from World Liberty Financial, a company founded by Trump and his sons, with $515 million from token sales and $65 million from equity sales. Additionally, $635 million in royalties came from "celebration coins," including the Trumpcoin memecoin business.
Trump's accounts reported over 15,500 purchases and roughly 5,700 sales. Remarkably, just 10 trading days accounted for about 25% of all trades, clustered around volatile market moments. For example:
The April 8th purchases at market lows were particularly successful, as the market rebounded strongly the next day.
Trump's accounts consistently buy quality stocks during market downturns when others panic sell. This was evident during the tariff-driven sell-off in April 2025 and again in February 2026 with software stocks like Oracle, ServiceNow, and Workday.
The portfolio concentrates on dominant mega-cap companies leading the AI buildout, including Nvidia, Apple, Microsoft, Broadcom, Amazon, Oracle, and Alphabet. This strategy leverages proven winners riding a massive mega-trend.
A significant portion of the portfolio is invested in companies with the US government as their largest customer, such as defense primes Boeing, Lockheed Martin, Northrop Grumman, Raytheon, and defense tech firms like Palantir and Axon. Intel also features prominently, benefiting from government equity stakes.
The portfolio is actively managed with frequent buying and selling, including same-day trades in major stocks like Microsoft, Amazon, and Meta. This rebalancing helps trim overvalued positions and rotate into better opportunities.
Despite a challenging environment for SaaS companies, Trump's accounts have aggressively bought into five major SaaS stocks:
Oracle (ORCL): Transitioning into a cloud and AI infrastructure leader with a massive backlog of $638 billion in performance obligations and strong revenue growth.
ServiceNow (NOW): A platform for enterprise operations integrating AI, showing subscription revenue growth and strong customer retention.
Adobe (ADBE): Known for creative software and AI product Firefly, with strong cash flow and a $25 billion buyback program signaling undervaluation.
Workday (WDAY): Cloud system for HR and finance, expanding AI solutions with growing revenue and margin outlook.
PTC (PTC): Industrial engineering software with strong recurring revenue growth and a significant backlog, benefiting from defense and AI-related contracts.
Trump's portfolio also includes several small-cap stocks with strategic significance:
CoreCivic (CXW): Private prison operator benefiting from increased immigration enforcement.
Geo Group (GEO): Another major private prison operator, complementing CoreCivic's position.
Iridium Communications (IRDM): Satellite network provider essential for global communications, including national security.
Penguin Solutions (PE NG): Provides specialized memory and compute systems for AI infrastructure, a critical but under-the-radar player.
Intuitive Machines (LUNR): A vertically integrated space company involved in spacecraft manufacturing, deep space navigation, and ground communication networks. It has rapidly expanded its backlog from a few hundred million to $1.1 billion, with contracts spanning NASA lunar missions, US Space Force, and commercial satellite manufacturing.
Intuitive Machines has transformed from a lunar landing hardware company into a full space prime contractor. It owns spacecraft manufacturing (via Lentas Space Systems), deep space navigation (Ket X), and ground antenna networks (Goonhilly and Comat). The company has diversified into civil space, defense, and commercial sectors, with optionality in lunar infrastructure and space-based data centers. This comprehensive integration and growing backlog position it as a potential 10x investment.
ConnectU Sciences is a preclinical regenerative tissue company addressing a new market created by the GLP-1 weight loss drug boom. Rapid weight loss from GLP-1 drugs causes tissue depletion and skin laxity, leading to accelerated aging appearances. Current aesthetic fillers only add volume without restoring underlying tissue.
ConnectU's platform, CXU, is a flowable regenerative tissue matrix mimicking the body's extracellular matrix (ECM). It acts as a scaffold supporting natural tissue regeneration rather than just filling space. CXU is a liquid-to-gel injectable that sets in about 10 minutes at body temperature, designed to support tissue in-growth.
President Trump's 2025 trading disclosures reveal a highly active and strategically managed portfolio focused on buying dips, investing in AI leaders, following government contracts, and actively rebalancing. His investments span large-cap tech and SaaS companies, strategic small caps, and a promising space company with potential for significant returns.
The sponsored segment on ConnectU Sciences highlights an innovative regenerative tissue company addressing a growing market need created by the GLP-1 drug wave, with a unique technology platform and a multi-billion-dollar addressable market.
As always, investors should conduct their own due diligence before making investment decisions.
